You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic Canada does not review or control the content on the other website, and is not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site not be licensed for sale in Canada.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
By choosing to accept, you acknowledge that you are a Certified Healthcare Professional.
SYMPLICITY SPYRAL™ RENAL DENERVATION (RDN) SYSTEM
Renal denervation for hypertension
Find courses, webinars, and other educational activities for hypertension and the Symplicity™ blood pressure procedure (also called renal denervation).
Professor Felix Mahfoud presents the SPYRAL HTN-ON MED pilot study data at ACC 2022 detailing the long-term safety and efficacy of renal denervation with the Symplicity blood pressure procedure.
Presentation Video on 3 Year Outcomes of SPYRAL HTN - ON MED Trial - (06:38)
The presentation video on 3 year outcomes of SPYRAL HTN - ON MED Trial.
More information (see more)
Less information (see less)
MACE risk reductions
Professors Felix Mahfoud, M.D., Roland Schmieder, M.D., and Flavio Ribichini, M.D.,discuss key fndings on RDN.
Real-world outcomes
Professor Felix Mahfoud discusses real-
world outcomes of the Symplicity procedure from the GLOBAL SYMPLICITY REGISTRY.
The science of the procedure
Professor Andrew Sharp explores the science of the Symplicity blood pressure procedure from a proceduralist’s perspective.
Browse online courses and many other educational resources about the Symplicity blood pressure procedure, clinical evidence, and practical clinical application.
Medscape’s education platform helps physicians learn about recent data with innovative interventional technology that can help patients achieve blood pressure control as an alternative to, or in addition to, typical management plans that include anti-hypertensive medications and lifestyle modifcations.
Radcliffe offers CME courses and webinars exploring renal denervation, clinical data, and many other topics, featuring Prof. Stefano Taddei, Prof. Atul Pathak, Prof. Andrew Sharp, Prof. Roland Schmeider, and other distinguished faculty.
WONDR Medical regularly introduces training resources and a wide array of video content in multiple languages at RDN:NOW.
The American Heart Association (AHA) offers a hypertension professional education series with new learning modules added regularly. Content includes webinars, spotlight series and podcasts.
This American College of Cardiology (ACC) education initiative platform helps learners evaluate and select evidence-based interventions and contemporary approaches for the treatment and control of hypertension.
Content includes webinars, podcasts, certifed cases, quick tip videos, gamifcation, patient case quizzes, and interactive cases/lessons.
See which types of patients could beneft from the Symplicity blood pressure procedure.
The Symplicity blood pressure procedure is supported by multiple clinical trials and a real-world patient registry.1-4
The Symplicity blood pressure procedure is changing how patients with hypertension can reduce their blood pressure.
Mahfoud F, Kandzari DE, Kario K, et al. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial. The Lancet. 2022;399:1401-1410.
Mahfoud F, Mancia G, Schmieder R, et al. Three-year safety and efficacy in the Global Symplicity Registry: Impact of antihypertensive medication burden on blood pressure reduction. Presented at PCR e-course 2020.
Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. The Lancet. 2020;395:1444-1451.
Kandzari DE, Böhm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. The Lancet. 2018;391(10137):2346.